We are live on ! Find out more
NUVB icon

Nuvation Bio

231 hedge funds and large institutions have $947M invested in Nuvation Bio in 2026 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 90 increasing their positions, 58 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more repeat investments, than reductions

Existing positions increased: 90 | Existing positions reduced: 58

45% more call options, than puts

Call options by funds: $5.27M | Put options by funds: $3.64M

27% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 37

4% more funds holding

Funds holding: 223231 (+8)

1.92% more ownership

Funds ownership: 61.7%63.62% (+1.9%)

44% less funds holding in top 10

Funds holding in top 10: 95 (-4)

50% less capital invested

Capital invested by funds: $1.89B → $947M (-$948M)

Holders
231
Holders Change
+8
Holders Change %
+3.59%
% of All Funds
2.84%
Holding in Top 10
5
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-44.44%
% of All Funds
0.06%
New
47
Increased
90
Reduced
58
Closed
37
Calls
$5.27M
Puts
$3.64M
Net Calls
+$1.63M
Net Calls Change
-$24.5M
Name Holding Trade Value Shares
Change
Change in
Stake
Swiss National Bank
51
Swiss National Bank
Switzerland
$1.88M
D.E. Shaw & Co
52
D.E. Shaw & Co
New York
$1.69M -$2.69M -482,816 -55%
TE
53
Tema ETFs
New York
$1.68M +$830K +148,906 +61%
TI
54
Tidal Investments
Wisconsin
$1.68M +$2.19M +392,754 New
State of Wisconsin Investment Board
55
State of Wisconsin Investment Board
Wisconsin
$1.62M +$675K +121,171 +47%
Corient Private Wealth
56
Corient Private Wealth
Florida
$1.48M -$914K -164,043 -32%
PBM
57
Propel Bio Management
California
$1.41M +$1.83M +329,296 New
Citigroup
58
Citigroup
New York
$1.35M +$1.41M +252,694 +401%
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$1.3M -$24K -4,308 -1%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$1.3M +$502K +90,114 +42%
T. Rowe Price Associates
61
T. Rowe Price Associates
Maryland
$1.3M -$13.4M -2,404,929 -89%
IP
62
Intellectus Partners
California
$1.25M +$27.9K +5,000 +2%
ACM
63
ACT Capital Management
Pennsylvania
$1.24M -$1.79M -320,500 -52%
AA
64
ALPS Advisors
Colorado
$1.21M +$6.97K +1,251 +0.4%
Russell Investments Group
65
Russell Investments Group
United Kingdom
$1.14M +$1.34M +241,244 +986%
JF
66
Jump Financial
Illinois
$1.13M +$518K +92,957 +55%
IC
67
IEQ Capital
California
$1M -$227K -40,709 -15%
XT
68
XTX Topco
Cayman Islands
$987K +$1.09M +195,322 +562%
Deutsche Bank
69
Deutsche Bank
Germany
$913K +$122K +21,938 +11%
BNP Paribas Financial Markets
70
BNP Paribas Financial Markets
France
$881K -$2.77M -496,563 -71%
AAM
71
AMI Asset Management
California
$826K +$367K +65,955 +52%
Wells Fargo
72
Wells Fargo
California
$815K -$457K -82,027 -30%
Tudor Investment Corp
73
Tudor Investment Corp
Connecticut
$760K +$988K +177,260 New
SC
74
Shay Capital
New York
$751K +$975K +175,056 New
Legal & General Group
75
Legal & General Group
United Kingdom
$747K -$104K -18,695 -10%

NUVB Hedge Fund Activity: Q1 2026 in Review

231 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio (NUVB) for Q1 2026, worth a combined $947M — down 50% from $1.89B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new NUVB positions and 37 closed out — a net gain of 10 holders — while 90 added to existing stakes and 58 trimmed.

The largest buyer was Duquesne Family Office, opening a new position worth an estimated $25.3M. The largest seller was Capricorn Fund Managers, exiting entirely with an estimated $14.2M sold.

  • 231 institutional investors held Nuvation Bio (NUVB) as of Q1 2026, up from 223 in Q4 2025.
  • Funds reported $947M of Nuvation Bio stock for Q1 2026, down 50% quarter-over-quarter.
  • 47 funds opened new Nuvation Bio positions in Q1 2026 and 37 closed out, a net change of +10 holders.
  • The largest Nuvation Bio buyer in Q1 2026 was Duquesne Family Office, an estimated $25.3M added.
  • The largest Nuvation Bio seller in Q1 2026 was Capricorn Fund Managers, an estimated $14.2M sold.

Based on aggregated 13F filings for Q1 2026.